e-Article
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Document Type
Article
Author
Hizal, M.; Bilgin, B.; Yücel, Ş.; Paksoy, N.; Aydıner, A.; Açıkgöz, Ö.; Bilici, A.; Sezer, A.; Gürbüz, M.; Demirkazık, A.; Ak, N.; Ayhan, M.; Erol, C.; Yalçın, B.; Şendur, M.A.N.; Demirkıran, A.; Mandel, N.M.; Shbair, A.; Gökmen, İ.; Başoğlu, T.; Yumuk, P.F.; Paydaş, S.; Demiray, A.G.; İriağaç, Y.; Şakalar, T.; Zeynelgil, E.; Tatlı, A.M.; Bahçeci, A.; Güven, D.C.; Caner, B.; Can, A.; Gülmez, A.; Karakaş, Y.
Source
In: Journal of Cancer Research and Clinical Oncology . (Journal of Cancer Research and Clinical Oncology, June 2022, 148(6):1501-1508)
Subject
Language
English
ISSN
14321335
01715216
01715216